Syndicated Report

InCrowd – Novel Coronavirus (COVID-19) Vaccine Development

July 17, 2020

Given the recent uptick in COVID-19 cases in the US, many InCrowd panelists have been reporting that they do not expect things to return to normal until a vaccine is developed and disseminated. In order to deepen our understanding of the COVID-19 vaccine landscape, InCrowd surveyed infectious disease specialists across the country to get their perception and predictions on the efficacy, impact, and competitive landscape of COVID-19 vaccines.

Please note, views in this survey reflect opinions only, as reported by responding physicians.

Methodology:

  • Method: 10-minute MicroSurvey via InCrowd
  • Crowds: Infectious disease doctors
  • Sample Size: n=100
  • Fielding Period: June 26th – July 6th

InCrowd’s other COVID-19 Tracking Reports:

  • This field is for validation purposes and should be left unchanged.